NPY signaling inhibits extended amygdala CRF neurons to suppress binge alcohol drinking Academic Article uri icon


MeSH Major

  • Behavior, Animal
  • Binge Drinking
  • Corticotropin-Releasing Hormone
  • Neural Inhibition
  • Neuropeptide Y
  • Receptors, Neuropeptide Y
  • Septal Nuclei
  • Signal Transduction


  • Binge alcohol drinking is a tremendous public health problem because it leads to the development of numerous pathologies, including alcohol abuse and anxiety. It is thought to do so by hijacking brain systems that regulate stress and reward, including neuropeptide Y (NPY) and corticotropin-releasing factor (CRF). The central actions of NPY and CRF have opposing functions in the regulation of emotional and reward-seeking behaviors; thus, dysfunctional interactions between these peptidergic systems could be involved in the development of these pathologies. We used converging physiological, pharmacological and chemogenetic approaches to identify a precise neural mechanism in the bed nucleus of the stria terminalis (BNST), a limbic brain region involved in pathological reward and anxiety behaviors, underlying the interactions between NPY and CRF in the regulation of binge alcohol drinking in both mice and monkeys. We found that NPY Y1 receptor (Y1R) activation in the BNST suppressed binge alcohol drinking by enhancing inhibitory synaptic transmission specifically in CRF neurons via a previously unknown Gi-mediated, PKA-dependent postsynaptic mechanism. Furthermore, chronic alcohol drinking led to persistent alterations in Y1R function in the BNST of both mice and monkeys, highlighting the enduring, conserved nature of this effect across mammalian species. Together, these data provide both a cellular locus and signaling framework for the development of new therapeutics for treatment of neuropsychiatric diseases, including alcohol use disorders.

publication date

  • January 2015



  • Academic Article



  • eng

PubMed Central ID

  • PMC4376619

Digital Object Identifier (DOI)

  • 10.1038/nn.3972

PubMed ID

  • 25751534

Additional Document Info

start page

  • 545

end page

  • 52


  • 18


  • 4